Liv Meert

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Sergio Amadori, Stefan Suciu, Dominik Selleslag et al. · Journal of Clinical Oncology · 2016 · 348 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

R. Willemze, Stefan Suciu, Giovanna Meloni et al. · Journal of Clinical Oncology · 2013 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

Claudio Viscoli, Raoul Herbrecht, Hamdi Akan et al. · Journal of Antimicrobial Chemotherapy · 2009 · 154 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

Raoul Herbrecht, Johan Maertens, Liliana Baila et al. · Bone Marrow Transplantation · 2010 · 151 citations

Medicine, Hematology, Immunology +17

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

Johan Maertens, Tom Lodewyck, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2022 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17